home / stock / lnsr / lnsr news


LNSR News and Press, LENSAR Inc. From 11/12/21

Stock Information

Company Name: LENSAR Inc.
Stock Symbol: LNSR
Market: NASDAQ
Website: lensar.com

Menu

LNSR LNSR Quote LNSR Short LNSR News LNSR Articles LNSR Message Board
Get LNSR Alerts

News, Short Squeeze, Breakout and More Instantly...

LNSR - LENSAR Announces Poster Presentations at the American Academy of Ophthalmology

Demonstrates LENSAR Laser’s Ability to Guide Improved Astigmatic Outcomes for Patients LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for...

LNSR - LENSAR, Inc. (LNSR) CEO Nick Curtis on Q3 2021 Results - Earnings Call Transcript

LENSAR, Inc. (LNSR) Q3 2021 Results Conference Call November 08, 2021 08:30 AM ET Company Participants Cameron Radinovic - Burns McClellan Nick Curtis - CEO Tom Staab - CFO Conference Call Participants Danielle Antalffy - SVB Leerink Ryan Zimmerman - BTIG Presentation Operator Good morning, a...

LNSR - LENSAR EPS misses by $0.06, beats on revenue

LENSAR (NASDAQ:LNSR): Q3 GAAP EPS of -$0.65 misses by $0.06. Revenue of $8.3M (+16.1% Y/Y) beats by $0.63M. Press Release For further details see: LENSAR EPS misses by $0.06, beats on revenue

LNSR - LENSAR Reports Third Quarter 2021 Financial Results and Provides Business Update

Third Quarter 2021 Procedure Volumes Increase 23% over 2020 Levels Cash and Cash Equivalents of $32.3 Million reflect Cash Utilization of $2.2 Million in the Quarter LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical...

LNSR - LENSAR to Report Third Quarter 2021 Financial Results on Monday, November 8, 2021

LENSAR, Inc. (NASDAQ: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced that the Company’s third quarter 2021 financial result...

LNSR - LENSAR to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced that Nick Curtis, Chief Executive Officer will present at the...

LNSR - LENSAR to Present at the H.C. Wainwright Ophthalmology Virtual Conference

LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced that Nick Curtis, Chief Executive Officer will present at the...

LNSR - LENSAR, Inc. (LNSR) CEO Nick Curtis on Q2 2021 Results - Earnings Call Transcript

LENSAR, Inc. (LNSR) Q2 2021 Results Earnings Conference Call August 05, 2021, 8:30 am ET Company Participants Lee Roth - Investor Relations, Senior Vice President of Investor Relations at Burns McClellan Nick Curtis - Chief Executive Officer Tom Staab - Chief Financial Officer Conference Call...

LNSR - LENSAR EPS beats by $0.12, beats on revenue

LENSAR (NASDAQ:LNSR): Q2 GAAP EPS of -$0.47 beats by $0.12. Revenue of $7.9M (+56.4% Y/Y) beats by $0.77M. Press Release For further details see: LENSAR EPS beats by $0.12, beats on revenue

LNSR - LENSAR Reports Second Quarter 2021 Financial Results and Provides Business Update

Second Quarter and First Half 2021 Procedure Volumes Increase 70% and 42% over 2020 Levels Cash and Cash Equivalents of $34.6 Million reflects Cash Utilization of $1.3 Million in the Second Quarter LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company&#x...

Previous 10 Next 10